NCT00970528View on ClinicalTrials.gov

Glucose Reduction by Early Acarbose Treatment in Basal Insulin

PHASE4CompletedINTERVENTIONAL
Enrollment

124

Participants

Timeline

Start Date

November 30, 2009

Primary Completion Date

March 31, 2012

Study Completion Date

March 31, 2012

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Acarbose (Glucobay, BAYG5421)

uptitrated 100mg three times a day with insulin glargine alone or in combination with metformin

DRUG

Voglibose (Basen)

uptitrated 0.3mg three times a day with insulin glargine alone or in combination with metformin

Trial Locations (11)

220-701

Wŏnju

602-714

Busan

463-500

Gyeonggi-do

471-701

Gyeonggi-do

602-739

Pusan

150-713

Seoul

705-717

Daegu

456-712

Jeonju

136-705

Seongbuk-gu Seoul

134-701

Seoul

135-710

Seoul

Sponsors

Lead Sponsor

Bayer
All Listed Sponsors
lead

Bayer

INDUSTRY